Sankalp Jain

Sankalp Jain

Auto-generated profile, based on publicly available information

Sankalp Jain

National Center for Advancing Translational Sciences (NCATS), National Institutes of Health , 9800 Medical Center Drive

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2021 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
SJSankalp Jain
Sankalp Jain
VSVishal B. Siramshetty
Vishal B. Siramshetty
VAVinicius Alves
Vinicius Alves
EMEugene Muratov
Eugene Muratov
NKNicole Kleinstreuer
Nicole Kleinstreuer
AZAlexey V. Zakharov
Alexey V. Zakharov

6 April 2018 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Open access
PDF file
SJSankalp Jain
Sankalp Jain
EKEleni Kotsampasakou
Eleni Kotsampasakou
GEGerhard Ecker
Gerhard Ecker
Cheminformatics datasets used in classification problems, especially those related to biological or physicochemical properties, are often imbalanced. This presents a major challenge in development of in silico prediction models, as the traditional machine learning algorithms are known to work best on balanced datasets. The class imbalance introduces a bias in the performance of these algorithms due to their preference towards the majority class. Here, we present a comparison of the performance of seven different meta-classifiers for their ability to handle imbalanced datasets, whereby Random Forest is used as base-classifier. Four different datasets that are directly (cholestasis) or indirectly (via inhibition of organic anion transporting polypeptide 1B1 and 1B3) related to liver toxicity were chosen for this purpose. The imbalance ratio in these datasets ranges between 4:1 and 20:1 for negative and positive classes, respectively. Three different sets of molecular descriptors for model development were used, and their performance was assessed in 10-fold cross-validation and on an independent validation set. Stratified bagging, MetaCost and CostSensitiveClassifier were found to be the best performing among all the methods. While MetaCost and CostSensitiveClassifier provided better sensitivity values, Stratified Bagging resulted in high balanced accuracies. Graphical Abstract

12 May 2010 in Journal of Molecular Modeling
Verified
Journal Article
Closed access
PDF file
PNPradeep Kumar Naik
Pradeep Kumar Naik
MSMani Srivastava
Mani Srivastava
PBPrasad Bajaj
Prasad Bajaj
SJSankalp Jain
Sankalp Jain
ADAbhishek Dubey
Abhishek Dubey
HSHarvinder Singh
Harvinder Singh

19 May 2017 in Journal of Computer-Aided Molecular Design
Verified
Journal Article
Open access
PDF file
SJSankalp Jain
Sankalp Jain
MGMelanie Grandits
Melanie Grandits
LRLars Richter
Lars Richter
GEGerhard Ecker
Gerhard Ecker
The bile salt export pump (BSEP) actively transports conjugated monovalent bile acids from the hepatocytes into the bile. This facilitates the formation of micelles and promotes digestion and absorption of dietary fat. Inhibition of BSEP leads to decreased bile flow and accumulation of cytotoxic bile salts in the liver. A number of compounds have been identified to interact with BSEP, which results in drug-induced cholestasis or liver injury. Therefore, in silico approaches for flagging compounds as potential BSEP inhibitors would be of high value in the early stage of the drug discovery pipeline. Up to now, due to the lack of a high-resolution X-ray structure of BSEP, in silico based identification of BSEP inhibitors focused on ligand-based approaches. In this study, we provide a homology model for BSEP, developed using the corrected mouse P-glycoprotein structure (PDB ID: 4M1M). Subsequently, the model was used for docking-based classification of a set of 1212 compounds (405 BSEP inhibitors, 807 non-inhibitors). Using the scoring function ChemScore, a prediction accuracy of 81% on the training set and 73% on two external test sets could be obtained. In addition, the applicability domain of the models was assessed based on Euclidean distance. Further, analysis of the protein–ligand interaction fingerprints revealed certain functional group-amino acid residue interactions that could play a key role for ligand binding. Though ligand-based models, due to their high speed and accuracy, remain the method of choice for classification of BSEP inhibitors, structure-assisted docking models demonstrate reasonably good prediction accuracies while additionally providing information about putative protein–ligand interactions.

1 September 2018 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
SJSankalp Jain
Sankalp Jain
MGMelanie Grandits
Melanie Grandits
GEGerhard Ecker
Gerhard Ecker
Prior to the clinical phases of testing, safety, efficacy and pharmacokinetic profiles of lead compounds are evaluated in animal studies. These tests are primarily performed in rodents, such as mouse and rats. In order to reduce the number of animal experiments, computational models that predict the outcome of these studies and thus aid in prioritization of preclinical candidates are heavily needed. However, although computational models for human off-target interactions with decent quality are available, they cannot easily be transferred to rodents due to lack of respective data. In this study, we assess the transferability of human P-glycoprotein activity data for development of in silico models to predict in vivo effects in rats and mouse using a structure-based approach. P-glycoprotein (P-gp) is an ATP-dependent efflux transporter that transports xenobiotic compounds such as toxins and drugs out of cells and has a broad substrate and inhibitor specificity. Being mostly expressed at barriers, it influences the bioavailability of drugs and thus contributes also to toxicity. Comparison of the binding site interaction profiles of human, rat and mouse P-gp derived from docking studies with a set of common inhibitors suggests that the inhibitors share potentially similar binding modes. These findings encourage the use of in vitro human P-gp data for predicting in vivo effects in rodents and thus contributes to the 3Rs (Replace, Reduce and Refine) of animal experiments.

21 December 2020 in Chemical Research in Toxicology
Verified
Journal Article
Open access
SJSankalp Jain
Sankalp Jain
UNUlf Norinder
Ulf Norinder
SESylvia E. Escher
Sylvia E. Escher
BZBarbara Zdrazil
Barbara Zdrazil
Hepatic steatosis (fatty liver) is a severe liver disease induced by the excessive accumulation of fatty acids in hepatocytes. In this study, we developed reliable in silico models for predicting hepatic steatosis on the basis of an in vivo data set of 1041 compounds measured in rodent studies with repeated oral exposure. The imbalanced nature of the data set (1:8, with the “steatotic” compounds belonging to the minority class) required the use of meta-classifiers—bagging with stratified under-sampling and Mondrian conformal prediction—on top of the base classifier random forest. One major goal was the investigation of the influence of different descriptor combinations on model performance (tested by predicting an external validation set): physicochemical descriptors (RDKit), ToxPrint features, as well as predictions from in silico nuclear receptor and transporter models. All models based upon descriptor combinations including physicochemical features led to reasonable balanced accuracies (BAs between 0.65 and 0.69 for the respective models). Combining physicochemical features with transporter predictions and further with ToxPrint features gave the best performing model (BAs up to 0.7 and efficiencies of 0.82). Whereas both meta-classifiers proved useful for this highly imbalanced toxicity data set, the conformal prediction framework also guarantees the error level and thus might be favored for future studies in the field of predictive toxicology.